Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
61.251,27
0,75%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Middlebrook Pharmaceuticals (MM) (MBRK) Middlebrook Pharmaceuticals (MM) (MBRK) Notizie

MBRK

Middlebrook Pharmaceuticals (MM) (MBRK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MBRK
DataOraFonteTitoloSimboloCompagnia
07/05/201023:08Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
04/05/201022:48Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
30/04/201022:30Business WireMiddleBrook Pharmaceuticals Files for Chapter 11 Bankruptcy ProtectionNASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
30/04/201022:07Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
23/03/201021:45Business WireMiddleBrook Pharmaceuticals Announces Board of Directors ResignationsNASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
17/03/201013:00Business WireMiddleBrook Pharmaceuticals Announces Expanded IncreaseRx® Promotion for MOXATAG®NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
16/03/201022:14Edgar (US Regulatory)Annual Report (10-K)NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
12/03/201015:00Business WireMiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 & Full-Year Results; Announces Reduction in Force; Engages Broadpoint...NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
03/02/201022:14Business WireMiddleBrook Pharmaceuticals Announces Promotion Partnership with DoctorDirectory.com for MOXATAG® (extended-release amoxicil...NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
05/01/201023:33Business WireMiddleBrook Pharmaceuticals Reports Inducement Grants Under NASDAQ Marketplace Rule 4350NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
21/12/200922:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
03/12/200922:07Business WireMiddleBrook Pharmaceuticals Reduces Field Sales Force & Corporate Staff, Receives Notice from Nasdaq Regarding Minimum Bid Pr...NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
17/11/200922:38Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
05/11/200913:08Business WireMiddleBrook Pharmaceuticals Reports Third Quarter 2009 ResultsNASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
15/10/200914:07Business WireMiddleBrook Pharmaceuticals Schedules Third Quarter 2009 Results Conference Call and WebcastNASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
14/10/200921:17Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
12/10/200922:00Business WireMOXATAG® Supports Health Education on FamilyDoctor.orgNASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
01/09/200915:05Business WireMiddleBrook Pharmaceuticals Announces Sales Force Realignment, Cost-Saving MeasuresNASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
06/08/200912:18Business WireMiddleBrook Pharmaceuticals Reports Second Quarter 2009 ResultsNASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
15/07/200913:13Business WireMiddleBrook Pharmaceuticals Announces $20 Maximum Copay Program for MOXATAG®NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
14/07/200914:13Business WireMiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for Second Quarter 2009 Financial and Operational ResultsNASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
01/07/200913:37Business WireMiddleBrook Pharmaceuticals Secures $10 Million Revolving Line of CreditNASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
26/06/200920:27Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
07/05/200912:52Business WireMiddleBrook Pharmaceuticals Reports First Quarter 2009 ResultsNASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
01/05/200914:00Business WireMiddleBrook Pharmaceuticals Launches MOXATAG™ Website, Announces Early Prescription Data for MOXATAGNASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
30/04/200922:37Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
20/04/200922:36Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
06/04/200914:22Business WireMiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for First Quarter 2009 Financial and Operational ResultsNASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
16/03/200921:15Business WireMiddleBrook Pharmaceuticals Launches MOXATAG™, the First and Only FDA-Approved Once-Daily AmoxicillinNASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
13/03/200915:40Business WireCompany Profile for MiddleBrook Pharmaceuticals, Inc.NASDAQ:MBRKMiddlebrook Pharmaceuticals (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MBRK

La tua Cronologia

BIT
ENEL
Enel
BIT
UCG
Unicredit
BIT
BFF
BFF Bank
BIT
ISP
Intesa Sanpaolo
BIT
LDO
Leonardo
BIT
IVG
Iveco Group NV
BIT
RACE
Ferrari NV
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
NEXI
Nexi S.p.A
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
MB
Mediobanca Banca di Cred...
BIT
PRY
Prysmian
BIT
STMMI
ST Microelectronics
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network